These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8254486)

  • 1. An experimental method for determining the Hildebrand solubility parameter of organic nonelectrolytes.
    Lin HM; Nash RA
    J Pharm Sci; 1993 Oct; 82(10):1018-26. PubMed ID: 8254486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting the solubility of drugs in solvent mixtures: multiple solubility maxima and the chameleonic effect.
    Escalera JB; Bustamante P; Martin A
    J Pharm Pharmacol; 1994 Mar; 46(3):172-6. PubMed ID: 8027922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solubility parameter of drugs for predicting the solubility profile type within a wide polarity range in solvent mixtures.
    Peña MA; Reíllo A; Escalera B; Bustamante P
    Int J Pharm; 2006 Sep; 321(1-2):155-61. PubMed ID: 16828993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple solubility maxima of oxolinic acid in mixed solvents and a new extension of Hildebrand solubility approach.
    Jouyban-Gharamaleki A; Romero S; Bustamante P; Clark BJ
    Chem Pharm Bull (Tokyo); 2000 Feb; 48(2):175-8. PubMed ID: 10705500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extended Hildebrand Solubility Approach: Prediction and Correlation of the Solubility of Itraconazole in Triacetin: Water Mixtures at 298.15°K.
    Jagdale S; Nawale RB
    Turk J Pharm Sci; 2020 Apr; 17(2):228-234. PubMed ID: 32454784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extended Hildebrand solubility approach: solubility of tolbutamide, acetohexamide, and sulfisomidine in binary solvent mixtures.
    Martin A; Miralles MJ
    J Pharm Sci; 1982 Apr; 71(4):439-42. PubMed ID: 7086654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Temperature and solvent effects in the solubility of some pharmaceutical compounds: Measurements and modeling.
    Mota FL; Carneiro AP; Queimada AJ; Pinho SP; Macedo EA
    Eur J Pharm Sci; 2009 Jun; 37(3-4):499-507. PubMed ID: 19406228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extended Hildebrand Solubility Approach: methylxanthines in mixed solvents.
    Martin A; Paruta AN; Adjei A
    J Pharm Sci; 1981 Oct; 70(10):1115-20. PubMed ID: 7299644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extended Hildebrand solubility approach: solubility of theophylline in polar binary solvents.
    Martin A; Newburger J; Adjei A
    J Pharm Sci; 1980 May; 69(5):487-91. PubMed ID: 7381727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A modification of the extended Hildebrand approach to predict the solubility of structurally related drugs in solvent mixtures.
    Bustamante P; Escalera B; Martin A; Selles E
    J Pharm Pharmacol; 1993 Apr; 45(4):253-7. PubMed ID: 8098363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Critical Assessment of the Hildebrand and Hansen Solubility Parameters for Polymers.
    Venkatram S; Kim C; Chandrasekaran A; Ramprasad R
    J Chem Inf Model; 2019 Oct; 59(10):4188-4194. PubMed ID: 31545900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of solubility properties of solvents and biomass on biomass pretreatment.
    Weerachanchai P; Kwak SK; Lee JM
    Bioresour Technol; 2014 Oct; 170():160-166. PubMed ID: 25129231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extended Hildebrand solubility approach: sulfonamides in binary and ternary solvents.
    Martin A; Wu PL; Velasquez T
    J Pharm Sci; 1985 Mar; 74(3):277-82. PubMed ID: 4009435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A cosolvency model to predict solubility of drugs at several temperatures from a limited number of solubility measurements.
    Jouyban A; Romero S; Chan HK; Clark BJ; Bustamante P
    Chem Pharm Bull (Tokyo); 2002 May; 50(5):594-9. PubMed ID: 12036011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extended Hansen solubility approach: naphthalene in individual solvents.
    Martin A; Wu PL; Adjei A; Beerbower A; Prausnitz JM
    J Pharm Sci; 1981 Nov; 70(11):1260-4. PubMed ID: 7299673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of solubility curves and melting properties of organic and pharmaceutical compounds.
    Nordström FL; Rasmuson AC
    Eur J Pharm Sci; 2009 Feb; 36(2-3):330-44. PubMed ID: 19022383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insights into Hildebrand Solubility Parameters - Contributions from Cohesive Energies or Electrophilicity Densities?
    Miranda-Quintana RA; Chen L; Smiatek J
    Chemphyschem; 2024 Jan; 25(1):e202300566. PubMed ID: 37883736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extended Hildebrand solubility approach: p-hydroxybenzoic acid in mixtures of dioxane and water.
    Wu PL; Martin A
    J Pharm Sci; 1983 Jun; 72(6):587-92. PubMed ID: 6875815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipophilicity determination of psoralens used in therapy through solubility and partitioning: comparison of theoretical and experimental approaches.
    Said A; Makki S; Muret P; Rouland JC; Toubin G; Millet J
    J Pharm Sci; 1996 Apr; 85(4):387-92. PubMed ID: 8901074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Solubility and related physicochemical properties of narcotic analgesics.
    Roy SD; Flynn GL
    Pharm Res; 1988 Sep; 5(9):580-6. PubMed ID: 2907788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.